Optimizing the multimodal approach to pancreatic cyst fluid diagnosis Developing a Volume-Based Triage Protocol

被引:26
作者
Chai, Siaw Ming [1 ]
Herba, Karl [2 ]
Kumarasinghe, M. Priyanthi [3 ]
de Boer, W. Bastiaan [1 ,3 ]
Amanuel, Benhur [1 ]
Grieu-Iacopetta, Fabienne [1 ]
Lim, Ee Mun [3 ]
Segarajasingam, Dev [2 ]
Yusoff, Ian [2 ]
Choo, Chris [1 ]
Frost, Felicity [1 ]
机构
[1] Queen Elizabeth II Med Ctr, PathWest Lab Med, Nedlands, WA 6009, Australia
[2] Queen Elizabeth II Med Ctr, Dept Gastroenterol, Nedlands, WA 6009, Australia
[3] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia
关键词
pancreatic cyst; cytopathology; carcinoembryonic antigen; KRAS mutation; endosonography; cytologic techniques; cyst fluid analysis; molecular analysis; FINE-NEEDLE-ASPIRATION; PAPILLARY-MUCINOUS NEOPLASMS; K-RAS; MOLECULAR-GENETICS; CANCER; LIMITATIONS; MALIGNANCY; PATHOLOGY; CYTOLOGY; LESIONS;
D O I
10.1002/cncy.21226
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND The objective of this study was to develop a triage algorithm to optimize diagnostic yield from cytology, carcinoembryonic antigen (CEA), and v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) testing on different components of a single pancreatic cyst fluid specimen. The authors also sought to determine whether cell block supernatant was suitable for CEA and KRAS testing. METHODS Fifty-four pancreatic cysts were triaged according to a volume-dependent protocol to generate fluid (neat and supernatant) and cell block specimens for cytology, comparative CEA, and KRAS testing. Follow-up histology, diagnostic cytology, or a combined clinicopathologic interpretation was recorded as the final diagnosis. RESULTS There were 26 mucinous cystic lesions and 28 nonmucinous cystic lesions with volumes ranging from 0.3 mL to 55 mL. Testing different components of the specimens (cell block, neat, and/or supernatant) enabled all laboratory investigations to be performed on 50 of 54 cyst fluids (92.6%). Interpretive concordance was observed in 17 of 17 cases (100%) and in 35 of 40 cases (87.5%) that had multiple components tested for CEA and KRAS mutations, respectively. An elevated CEA level (>192 ng/mL) was the most sensitive test for the detection of a mucinous cystic lesion (62.5%) versus KRAS mutation (56%) and positive cytology (61.5%). KRAS mutations were identified in 2 of 25 mucinous cystic lesions (8%) in which cytology and CEA levels were not contributory. CONCLUSIONS A volume-based protocol using different components of the specimen was able to optimize diagnostic yield in pancreatic cyst fluids. KRAS mutation testing increased diagnostic yield when combined with cytology and CEA analysis. The current results demonstrated that supernatant is comparable to neat fluid and cell block material for CEA and KRAS testing. Cancer (Cancer Cytopathol) 2013. (c) 2012 American Cancer Society.
引用
收藏
页码:86 / 100
页数:15
相关论文
共 25 条
  • [1] Serous cystadenoma of the pancreas - Limitations and pitfalls of endoscopic ultrasound-guided fine-needle aspiration biopsy
    Belsley, Nicole A.
    Pitman, Martha B.
    Lauwers, Gregory Y.
    Brugge, William R.
    Deshpande, Vikram
    [J]. CANCER CYTOPATHOLOGY, 2008, 114 (02) : 102 - 110
  • [2] Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS
    Brandwein, SL
    Farrell, JJ
    Centeno, BA
    Brugge, WR
    [J]. GASTROINTESTINAL ENDOSCOPY, 2001, 53 (07) : 722 - 727
  • [3] Diagnosis of pancreatic cystic neoplasms: A report of the cooperative pancreatic cyst study
    Brugge, WR
    Lewandrowski, K
    Lee-Lewandrowski, E
    Centeno, BA
    Szydlo, T
    Regan, S
    del Castillo, CF
    Warshaw, AL
    [J]. GASTROENTEROLOGY, 2004, 126 (05) : 1330 - 1336
  • [4] Cyst Fluid Carcinoembryonic Antigen Is an Accurate Diagnostic Marker of Pancreatic Mucinous Cysts
    Cizginer, Sevdenur
    Turner, Brian
    Bilge, A. Reyyan
    Karaca, Cetin
    Pitman, Martha B.
    Brugge, William R.
    [J]. PANCREAS, 2011, 40 (07) : 1024 - 1028
  • [5] High Prevalence of Pancreatic Cysts Detected by Screening Magnetic Resonance Imaging Examinations
    de Jong, Koen
    Nio, C. Yung
    Hermans, John J.
    Dijkgraaf, Marcel G.
    Gouma, Dirk J.
    van Eijck, Casper H. J.
    van Heel, Eddy
    Klass, Gunter
    Fockens, Paul
    Bruno, Marco J.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (09) : 806 - 811
  • [6] Mucinous cystic neoplasms of the pancreas: pathology and molecular genetics
    Fukushima, Noriyoshi
    Fukayama, Masashi
    [J]. JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 2007, 14 (03): : 238 - 242
  • [7] Molecular genetics of intraductal papillary-mucinous neoplasms of the pancreas
    Furukawa, Toru
    [J]. JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 2007, 14 (03): : 233 - 237
  • [8] The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology
    Khalid, A
    McGrath, KM
    Zahid, M
    Wilson, M
    Brody, D
    Swalsky, P
    Moser, AJ
    Lee, KK
    Slivka, A
    Whitcomb, DC
    Finkelstein, S
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2005, 3 (10) : 967 - 973
  • [9] Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study
    Khalid, Asif
    Zahid, Maliha
    Finkelstein, Sydney D.
    LeBlanc, Julia K.
    Kaushik, Neeraj
    Ahmad, Nuzhat
    Brugge, William R.
    Edmundowicz, Steven A.
    Hawes, Robert H.
    McGrath, Kevin M.
    [J]. GASTROINTESTINAL ENDOSCOPY, 2009, 69 (06) : 1095 - 1102
  • [10] Pancreatic cancer
    Maitra, Anirban
    Hruban, Ralph H.
    [J]. ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2008, 3 : 157 - 188